Cancer Stage vs Mortality Endpoints in Screening Trials?
TOPLINE: Late-stage cancer incidence may be a suitable alternative endpoint to cancer-specific mortality in lung and ovarian cancer screening trials, but not in breast, colorectal, or prostate cancer screening trials, new research showed. METHODOLOGY: …